Orgenesis INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
ORGS
Orgenesis INCSCHEDULE 13G: Neurocords LLC and Ariel Malik Disclose Significant 18.84% Passive Stake in Orgenesis, Inc.
Neurocords LLC and Ariel Malik have disclosed a significant passive ownership stake of 18.84% in Orgenesis, Inc. through a Schedule 13G filing.